About us

ExCulture is developing an animal-free alternative to heparin using bio-based secondary feedstocks.

Our technology focuses on processing biowaste-derived material into complex biopharmaceutical compounds, with heparin as our showcase product. By working with non-animal input streams, we aim to contribute to a more resilient and sustainable supply of heparin-like materials.

Our team combines expertise in biotechnology, bioprocess development, and business strategy. Together, we are working toward a scalable process for producing complex molecules from renewable biological sources.